Magnetic fluorescent microparticles as markers for particle transfer in extracorporeal blood purification

被引:12
作者
Ettenauer, Marion [1 ]
Posnicek, Thomas [1 ]
Brandl, Martin [1 ]
Weber, Viktoria [1 ]
Falkenhagen, Dieter [1 ]
机构
[1] Danube Univ Krems, Ctr Biomed Technol, A-3500 Krems, Austria
关键词
D O I
10.1021/bm700664q
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The microspheres-based detoxification system (MDS) is a combined membrane-adsorption system for extracorporeal blood purification in which adsorbent microparticles are recirculated in an extracorporeal filtrate circuit. Because the plasma filter represents the only barrier between the adsorbents and the patient's blood, there is the potential risk of particle entrance into the patient in case of a membrane rupture. To guarantee first fault safety of the system required for clinical application, magnetic fluorescent microparticles are added as markers to the adsorbent circuit. Detection of these particles in the venous blood line results in immediate shutdown of the pumps. Magnetic beads were functionalized with cresyl violet and tested with an in vitro setup of the particle detector to assess the detection limit in different matrices (water versus blood) as well as the influence of flow rate and particle size on the signal. In addition, biocompatibility and influence of sterilization on the performance of the particles were assessed. Functionalization of the magnetic particles with cresyl violet yielded fluorescent particles that were stable at 4 C for at least 12 months. No leakage of dye was detectable, and the particles were neither cytotoxic nor mutagenic. The particles could be steam sterilized without significant loss in fluorescence intensity. With an in vitro setup of the particle detector, 0.1 mg and 5 mg of particles were reproducibly detectable in water and blood, respectively.
引用
收藏
页码:3693 / 3696
页数:4
相关论文
共 13 条
[1]   Therapeutic apheresis - State of the art in the year 2005 [J].
Bosch, T .
THERAPEUTIC APHERESIS AND DIALYSIS, 2005, 9 (06) :459-468
[2]   Detection of fluorescently labeled microparticles in blood [J].
Brandl, M ;
Hartmann, J ;
Posnicek, T ;
Ausenegg, FR ;
Leitner, A ;
Falkenhagen, D .
BLOOD PURIFICATION, 2005, 23 (03) :181-189
[3]  
Cruz DN, 2007, CONTRIB NEPHROL, V156, P444
[4]  
FALKENHAGEN D, 1994, BIOMED TECH, V39, P105
[5]   Characterisation of Dynabeads® by magnetization measurements and Mossbauer spectroscopy [J].
Fonnum, G ;
Johansson, C ;
Molteberg, A ;
Morup, S ;
Aksnes, E .
JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 2005, 293 (01) :41-47
[6]   Particle leakage in extracorporeal blood purification systems based on microparticle suspensions [J].
Hartmann, J ;
Schildboeck, C ;
Brandl, M ;
Falkenhagen, D .
BLOOD PURIFICATION, 2005, 23 (04) :282-286
[7]   Technology Insight:: artificial extracorporeal liver support -: how does Prometheus® compare with MARS®? [J].
Krisper, Peter ;
Stauber, Rudolf E. .
NATURE CLINICAL PRACTICE NEPHROLOGY, 2007, 3 (05) :267-276
[9]   ACUTE HEMODYNAMIC-EFFECTS AND BLOOD POOL KINETICS OF POLYSTYRENE MICROSPHERES FOLLOWING INTRAVENOUS ADMINISTRATION [J].
SLACK, JD ;
KANKE, M ;
SIMMONS, GH ;
DELUCA, PP .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (06) :660-664
[10]   A survey of blood purification techniques [J].
Stegmayr, BG .
TRANSFUSION AND APHERESIS SCIENCE, 2005, 32 (02) :209-220